What is CVE-2017-12714?

CVE-2017-12714 is a medium-severity vulnerability in Abbott Accent, classified under Improper Restriction of Power Consumption. CVSS score: 6.5/10. Published 2018-04-25.

How severe is CVE-2017-12714?

Medium severity. CVSS v3 base score is 6.5 out of 10.

Vulnerability in Abbott Accent

CVE-2017-12714

Abbott Laboratories pacemakers manufactured prior to Aug 28, 2017 do not restrict or limit the number of correctly formatted "RF wake-up" commands that can be received, which may allow a nearby attacker to repeatedly send commands to reduc…

EPSS: 0.007 (47.4th percentile) — read the EPSS interpretation.

CVSS v3 metric

CVSS v3 base score 6.5 (Medium). Vector: CVSS:3.0/AV:A/AC:L/PR:N/UI:N/S:U/C:N/I:N/A:H.

Affected products

Weakness classification (CWE)

CWE-920 — Improper Restriction of Power Consumption

References

ics-cert@hq.dhs.gov (US Government Resource, Third Party Advisory, x_refsource_MISC)
ics-cert@hq.dhs.gov (VDB Entry, Third Party Advisory, vdb-entry, x_refsource_BID)

Frequently asked questions

What is CVE-2017-12714?: CVE-2017-12714 is a medium-severity vulnerability in Abbott Accent, classified under Improper Restriction of Power Consumption. CVSS score: 6.5/10. Published 2018-04-25.
How severe is CVE-2017-12714?: Medium severity. CVSS v3 base score is 6.5 out of 10.